Cardiovascular diseases, including myocardial infarction (MI), represent the main worldwide
cause of mortality and morbidity. In this scenario, to contrast the irreversible damages …

Conspectus Cardiovascular disease (CVD) is a major health problem worldwide. Since
adult cardiomyocytes irreversibly withdraw from the cell cycle soon after birth, it is hard for …

Acute myocardial infarction (MI) is a common cardiovascular disease with high mortality. In
this study, an injectable thermosensitive hydrogel of chitosan (CS)/dextran (DEX)/β …

Introduction This study evaluates the effectiveness of a combined regimen involving
injectable hydrogels for the treatment of experimental myocardial infarction. Patient …

Cell therapy has the potential to regenerate cardiac tissue and treat a variety of cardiac
diseases which are currently without effective treatment. This novel approach to treatment …

Adipose-derived stem cells (ASCs) isolated from domestic animals fulfill the qualitative
criteria of mesenchymal stem cells, including the capacity to differentiate along multiple …

Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat
ischemic heart disease (IHD) due to their abundance, renewable sources, minor …

Myocardial infarction (MI) is associated with inflammatory reaction, which is a pivotal
component in MI pathogenesis. Moreover, excessive inflammation post-MI can lead to …

Mesenchymal stem cell therapy has emerged as a promising approach for the treatment of
myocardial infarction. However, the challenge of low cell survival and retention post …

Myocardial infarction (MI) poses a substantial threat to human health, prompting extensive
research into effective treatment modalities. Preclinical studies have demonstrated the …